On Tuesday, Nov. 6, 2018, at a press conference at the Society for Neuroscience’s annual Meeting, National Institutes of Health directors will discuss how NIH is marshalling resources, primarily through the HEAL (Helping to End Addiction Long-term) Initiative, to come up with short- and long-term solutions for countering the pain and opioid crisis.
Source: nimh

NIH BRAIN Initiative Cell Census Network (BICCN) has debuted its first data release, which focuses on motor cortex. In a related development, researchers have discovered cellular secrets of key social behaviors – mating, parenting, and aggression – in mouse hypothalamus.
Source: nimh

Mark Niciu, MD, PhD, talks about his experience in the Clinical Fellowship Program at NIMH.
Source: nimh

Jobert Vargas, BS, talks about his experience in the UCL-NIMH Joint Doctoral Program in Neuroscience.
Source: nimh

Gioia Guerrieri DO, FAPA, talks about her experience in the PGY4 Residency Training and Clinical Fellowship Program & NIMH
Source: nimh

Joshua A. Gordon, M.D., Ph.D., director of the National Institute of Mental Health (NIMH), and Ellen Leibenluft, M.D., chief of the Section on Mood Dysregulation and Neuroscience and co-chief of the Emotion and Development Branch in the NIMH Intramural Research Programs, have been elected as members of the National Academy of Medicine.
Source: nimh

Dr. Gordon discusses the presence—and negative impact—of bias in science and how we can take positive steps as individuals and organizations to challenge these assumptions and combat their damaging effects.
Source: nimh

In recognition of National Depression Screening Day, NIMH is hosting a Twitter chat on depression, a common but serious mood disorder. The event will be held on Thursday, October 11, 2018, 11:00AM―12:00 PM ET. This chat will cover the signs and symptoms, risk factors, and treatments for depression.
Source: nimh

Research tells us that severe stress can cause all kinds of adverse health outcomes, including an increased risk for mental illnesses. Dr. Gordon discusses how NIMH is trying to move the field of stress research forward, toward the translation of basic findings into clinical advances.
Source: nimh

The NIH-funded NeuroBioBank (NBB) was established in September 2013 as a national resource for investigators utilizing human post-mortem brain tissue and related biospecimens for their research to understand conditions of the nervous system. We seek to begin a recompetition for fiscal year 2019 to continue this largely successful program. The envisioned NBB 2.0 would benefit from lessons learned in the first iteration and would aim to increase the number of brains collected and distributed.
Source: nimh